Literature DB >> 7310418

Platelet monoamine oxidase activity and headache.

V Glover, R Peatfield, R Zammit-Pace, J Littlewood, M Gawel, F C Rose, M Sandler.   

Abstract

Mean platelet monoamine oxidase activity was reduced compared with control values in groups of headache-free male (but not female) patients suffering from classical migraine and from tension headache. Mean activity in male cluster patients, headache free, both during acute and quiescent phases of their illness, was also notably reduced. Retesting some migraine subjects after up to four years, showed that low activity may be a persistent feature: the correlation coefficient for repeated assays was 0.91 (p less than 0.01). There was no relationship between platelet monoamine oxidase activity and history of dietary migraine. A subgroup of headache patients with permanently low monoamine oxidase activity values may have been defined.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7310418      PMCID: PMC491137          DOI: 10.1136/jnnp.44.9.786

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  18 in total

1.  Migraine in children.

Authors:  B VAHLQUIST
Journal:  Int Arch Allergy Appl Immunol       Date:  1955

2.  Cyclic changes in platelet dynamics and the pathogenesis and prophylaxis of migraine.

Authors:  S V Deshmukh; J S Meyer
Journal:  Headache       Date:  1977-07       Impact factor: 5.887

3.  Substrate- and inhibitor-related characteristics of human platelet monoamine oxidase.

Authors:  C H Donnelly; D L Murphy
Journal:  Biochem Pharmacol       Date:  1977-05-01       Impact factor: 5.858

4.  Letter: Monoamine oxidase and migraine.

Authors:  E Hanington
Journal:  Lancet       Date:  1974-11-09       Impact factor: 79.321

5.  Beta-phenylethylamine: a specific substrate for type B monoamine oxidase of brain.

Authors:  H Y Yang; N H Neff
Journal:  J Pharmacol Exp Ther       Date:  1973-11       Impact factor: 4.030

6.  A phenylethylamine oxidising defect in migraine.

Authors:  M Sandler; M B Youdim; E Hanington
Journal:  Nature       Date:  1974-07-26       Impact factor: 49.962

7.  Plasma serotonin in migraine and stress.

Authors:  M Anthony; H Hinterberger; J W Lance
Journal:  Arch Neurol       Date:  1967-05

8.  A study of the activity of platelet monoamine oxidase in patients with migraine headaches or with 'cluster headaches'.

Authors:  G Bussone; P Giovannini; A Boiardi; R Boeri
Journal:  Eur Neurol       Date:  1977       Impact factor: 1.710

9.  Transitory decrease in platelet monoamine-oxidase activity during migraine attacks.

Authors:  V Glover; M Sandler; E Grant; F C Rose; D Orton; M Wilkinson; D Stevens
Journal:  Lancet       Date:  1977-02-19       Impact factor: 79.321

10.  Platelet aggregability in migraine.

Authors:  J R Couch; R S Hassanein
Journal:  Neurology       Date:  1977-09       Impact factor: 9.910

View more
  6 in total

1.  Cerebral cortical blood flow maps are reorganized in MAOB-deficient mice.

Authors:  O U Scremin; D P Holschneider; K Chen; M G Li; J C Shih
Journal:  Brain Res       Date:  1999-04-03       Impact factor: 3.252

2.  Pressor sensitivity to tyramine in patients with headache: relationship to platelet monoamine oxidase and to dietary provocation.

Authors:  R Peatfield; J T Littlewood; V Glover; M Sandler; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-09       Impact factor: 10.154

3.  Low platelet monoamine oxidase activity in headache: no correlation with phenolsulphotransferase, succinate dehydrogenase, platelet preparation method or smoking.

Authors:  J Littlewood; V Glover; M Sandler; R Peatfield; R Petty; F Clifford Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-04       Impact factor: 10.154

4.  Altered platelet monoamine oxidase-B activity in idiopathic Parkinson's disease.

Authors:  Maroof Husain; Rakesh Shukla; Madhu Dikshit; Pradeep K Maheshwari; Devika Nag; Rikhab C Srimal; Prahlad K Seth; Vinay K Khanna
Journal:  Neurochem Res       Date:  2009-03-04       Impact factor: 3.996

5.  beta-Carbolines as selective monoamine oxidase inhibitors: in vivo implications.

Authors:  V Glover; J Liebowitz; I Armando; M Sandler
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

6.  Platelet size: no correlation with migraine or monoamine oxidase activity.

Authors:  R C Peatfield; M J Gawel; D L Guthrie; T C Pearson; V Glover; J Littlewood; M Sandler; F C Rose
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-09       Impact factor: 10.154

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.